Skip to main content

CITADEL ADVISORS LLC

Position in JSPR — Jasper Therapeutics, Inc.

CIK 1423053 MIAMI, FL

Position in JSPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
0
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2024
8 quarters on record

Common Shares in JSPR Over Time

Shares Held

Position Value (USD)

Derivatives in JSPR

reported options exposure · as of Mar 31, 2026
CallValue
$40,383
CallShares
46,100
PutValue
$24,528
PutShares
28,000

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Mar 31, 2026

CITADEL ADVISORS LLC holds $5,780,974,653 across 374 Biotechnology names.

# Ticker Company Shares Value (USD) Open

All Filings in JSPR

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $40,383 46,100
2026-03-31 $24,528 28,000
2025-12-31 $88,206 48,200
2025-12-31 $45,750 25,000
2025-09-30 $105,910 44,500
2025-09-30 $41,412 17,400
2025-09-30 $1,402,888 589,449
2025-06-30 $97,125 17,500
2025-06-30 $2,277,963 410,444
2025-03-31 $1,613,231 375,170
2025-03-31 $34,400 8,000
2025-03-31 $95,460 22,200
2024-12-31 $273,664 12,800
2024-12-31 $9,056,781 423,610
2024-12-31 $32,070 1,500
2024-09-30 $2,662,818 141,564
2024-09-30 $30,096 1,600
2024-09-30 $73,359 3,900
2024-03-31 $475,925 16,210
2024-03-31 $111,568 3,800
2024-03-31 $82,208 2,800